CN114681552B - 麝香祛痛巴布膏剂及其制备方法 - Google Patents
麝香祛痛巴布膏剂及其制备方法 Download PDFInfo
- Publication number
- CN114681552B CN114681552B CN202210396925.7A CN202210396925A CN114681552B CN 114681552 B CN114681552 B CN 114681552B CN 202210396925 A CN202210396925 A CN 202210396925A CN 114681552 B CN114681552 B CN 114681552B
- Authority
- CN
- China
- Prior art keywords
- musk
- cataplasm
- relieving
- ethanol
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000402754 Erythranthe moschata Species 0.000 title claims abstract description 35
- 208000002193 Pain Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 17
- 239000011159 matrix material Substances 0.000 claims abstract description 15
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 9
- 239000003906 humectant Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- 238000002791 soaking Methods 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 239000000499 gel Substances 0.000 claims description 12
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 12
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 11
- 239000008273 gelatin Substances 0.000 claims description 11
- 229920000159 gelatin Polymers 0.000 claims description 11
- 235000019322 gelatine Nutrition 0.000 claims description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 10
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 229940113115 polyethylene glycol 200 Drugs 0.000 claims description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 7
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 7
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical group COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 7
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 7
- 229940041616 menthol Drugs 0.000 claims description 7
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims description 5
- 244000020518 Carthamus tinctorius Species 0.000 claims description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 5
- 244000131316 Panax pseudoginseng Species 0.000 claims description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000010238 camphora Substances 0.000 claims description 4
- 229940025250 camphora Drugs 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000009286 sanguis draxonis Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 3
- 241000723346 Cinnamomum camphora Species 0.000 claims description 3
- 241000405414 Rehmannia Species 0.000 claims description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 3
- 229940116229 borneol Drugs 0.000 claims description 3
- 229930008380 camphor Natural products 0.000 claims description 3
- 229960000846 camphor Drugs 0.000 claims description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 3
- 239000009136 dragon's blood Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 2
- 241001043298 Croton draco Species 0.000 claims 1
- 238000010030 laminating Methods 0.000 claims 1
- 238000011068 loading method Methods 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 239000011505 plaster Substances 0.000 abstract description 5
- 238000007493 shaping process Methods 0.000 abstract description 4
- 230000002844 continuous effect Effects 0.000 abstract description 3
- 239000000853 adhesive Substances 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229940040145 liniment Drugs 0.000 description 6
- 239000000865 liniment Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 244000153234 Hibiscus abelmoschus Species 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 240000004824 Trimezia steyermarkii Species 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及麝香祛痛巴布膏剂及其制备方法，包括以下步骤：按质量百分数计，取2％～8％的基质加入到0.5％～5％的保湿剂中，分散均匀后加入到86.7％～97.4％的麝香浸膏中，再加入0.1％～0.3％的交联剂，搅拌至溶解完全得到凝胶，再经过涂布、覆膜、静置和切片，得到麝香祛痛巴布膏剂。本发明贴敷膏剂载药量大，持续效果好，耐热、黏附力、赋形性、含量均匀度、透皮吸收性能、稳定性综合得分高，携带和使用方便。
Description
技术领域
本发明涉及医药领域，具体涉及麝香祛痛巴布膏剂及其制备方法。
背景技术
麝香浸膏由人工麝香、红花、樟脑、独活、冰片、龙血竭、薄荷脑、地黄、三七、乙醇配制而成。功能活血祛瘀，疏经活络，消肿止痛。用于各种跌打损伤，瘀血肿痛，风湿瘀阻，关节疼痛。使用时，取本品涂搽患处，按摩5-10分钟至患处发热，一日2-3次；软组织扭伤严重或有出血者，将药液浸湿的棉垫敷于患处。本品含乙醇、薄荷脑、冰片等易挥发物质，涂于患处，数分钟后即挥发。对于扭伤严重者，需要将药液浸湿的棉垫敷于患处，以延长药物作用时间、增强使用效果，但是棉垫容易移位或脱落，给部分患者带来不便。
巴布膏，又称凝胶贴膏，是指原料药物与适宜的亲水性基质混匀后涂布于背衬材料上制成的贴膏剂。巴布膏具有载药量大、作用时间长、对皮肤刺激小等优点。常用基质有聚丙烯酸钠、羧甲纤维素钠、明胶、甘油和微粉硅胶等。经过查阅科技文献和试验，以麝香浸膏的有效成分为主成分，分别以聚丙烯酸钠、羧甲纤维素钠、明胶、甘油和微粉硅胶等作为基质，结果黏附力、赋形性、耐热性、透皮吸收效果等理化指标均不甚理想，有必要提供一种指标结果更好的巴布膏。
发明内容
本发明的目的在于克服现有技术不足，提供一种麝香祛痛巴布膏剂及其制备方法，在不影响膏剂药用性能的同时，提升其黏附力和透皮吸收效果。
为达到上述技术目的，本发明巴布膏剂的技术方案是：
按质量百分数计，包括基质2％～8％、交联剂0.1％～0.3％、保湿剂0.5％～5％以及86.7％～97.4％的麝香浸膏。
进一步地，基质包括质量比为(2～5)：(0～1.0)：(0～2)的聚丙烯酸钠、羧甲基壳聚糖和明胶。
进一步地，交联剂为京尼平。
进一步地，保湿剂为聚乙二醇200。
进一步地，麝香浸膏由如下质量份的原料加乙醇浸提得到：人工麝香0.33份、红花1份、樟脑30份、独活1份、冰片20份、龙血竭0.33份、薄荷脑10份、地黄20份和三七0.33份。
本发明制备方法的技术方案是：包括以下步骤：
按质量百分数计，取2％～8％的基质加入到0.5％～5％的保湿剂中，分散均匀后加入到86.7％～97.4％的麝香浸膏中，再加入0.1％～0.3％的交联剂，搅拌至溶解完全得到凝胶，再经过涂布、覆膜、静置和切片，得到麝香祛痛巴布膏剂。
进一步地，麝香浸膏的制备步骤包括：取人工麝香0.33g、三七0.33g和红花1g，分别用50％乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；地黄20g用50％乙醇100mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；龙血竭0.33g和独活1g分别用乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；冰片20g和樟脑30g加入乙醇100mL搅拌使溶解，混匀，加入50％乙醇700mL，加入上述各浸渍液，混匀；将薄荷脑10g用适量50％乙醇溶解，加入上述药液中，加50％乙醇至总量为1000mL，混匀，静置，滤过，即得。
进一步地，涂布是将凝胶涂布在防渗布上。
进一步地，覆膜后静置24h再切片。
进一步地，切片的尺寸为40mm×40mm，每片含药量为1.5～2.5g。
与现有技术相比，本发明的有益效果包括：
1.本发明贴敷膏剂载药量大，一片凝胶药量相对擦剂一次喷药量能够提升十倍以上，持续效果好，可以持续8h缓慢释放药量(擦剂喷药后约1min药物就被吸收)，耐热、黏附力、赋形性、含量均匀度、透皮吸收性能、稳定性综合得分高。
2.携带和使用方便，即撕即贴，常温放置无流膏或渗油现象，不会沾到衣物上；黏着力合适，在1208～1830mN，在保证贴敷性好的同时，又不会紧贴皮肤，保证使用后轻松取下，避免拉伤皮肤。
3.使用后，无膏剂残留在皮肤上，有效避免传统膏药残留现象，方便清理。
进一步地，本发明采用的基质利于巴布膏涂布成型，且其中的羧甲基壳聚糖具有止血、愈合、抗菌抗感染、镇痛作用，利于提高巴布膏剂的药效。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
实施例一
本实施例产品处方及制法：
(1)人工麝香0.33g红花1g樟脑30g独活1g冰片20g龙血竭0.33g薄荷脑10g地黄20g三七0.33g
(2)以上9味药材，取人工麝香、三七、红花，分别用50％乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；地黄用50％乙醇100mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；龙血竭、独活分别用乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；冰片、樟脑加入乙醇100mL搅拌使溶解，混匀，加入50％乙醇700mL，加入上述各浸渍液，混匀；前述8味药材50％(wt)乙醇用量合计920mL，即每组原料对应的乙醇用量为该组原料的总乙醇量；将薄荷脑用适量(如20～30mL)50％乙醇溶解，加入上述药液中，加50％乙醇至总量为1000mL，混匀，静置，滤过，即得麝香浸膏药液。
(3)凝胶制备：取聚丙烯酸钠(2.2％)、羧甲基壳聚糖(0.8％)、明胶(2％)(由聚丙烯酸钠、羧甲基壳聚糖和明胶组成5％的基质)、京尼平(0.1％)、聚乙二醇200(0.5％)、麝香浸膏药液(94.4％)。先用聚乙二醇200将基质分散均匀后，再加入到麝香浸膏中，最后加入交联剂，这样基质容易在所得凝胶中分散开，不易结团。
(4)涂布：将凝胶均匀涂布在防渗布上，贴上膜放置24h再切片即得麝香祛痛巴布膏剂。本实施例所得膏剂易涂布，易成形，涂布后表面光滑。涂布后先放置再切片，能够保证膏剂更好地固化。
对本实施例制得的样品以及申请人所产的本草纲目麝香祛痛擦剂进行测试，结果如下表1所示。
表1实施例一制得的麝香祛痛巴布膏剂和麝香祛痛擦剂测试对比
由表1可知，本发明贴敷膏剂载药量大，一片凝胶约2g药量(相对擦剂一次喷药量提升十倍以上)，持续效果好，可以持续8h缓慢释放药量(擦剂喷药后约1min药物就被吸收)。
实施例二
步骤(3)采用2.5％的聚丙烯酸钠，0.6％的羧甲基壳聚糖、1％的明胶、0.05％的京尼平，5％的聚乙二醇200，90.85％的麝香浸膏药液，其它步骤及条件同实施例一，制得麝香祛痛巴布膏剂。
实施例三
步骤(3)采用2％的聚丙烯酸钠，1％的羧甲基壳聚糖、1.8％的明胶、0.15％的京尼平，0.6％的聚乙二醇200，94.45％的麝香浸膏药液，其它步骤及条件同实施例一，制得麝香祛痛巴布膏剂。
对比例一
采用聚乙二醇600替换聚乙二醇200，其它步骤及条件同实施例一。
对比例二
取等量的聚丙烯酸钠、羧甲纤维素钠、明胶、甘油和微粉硅胶混合，以该混合物替换实施例一的基质(聚丙烯酸钠、羧甲基壳聚糖和明胶，总量为5％)，用量及其它步骤条件同实施例一。
对比例三
基质仅采用5％的羧甲基壳聚糖，用量及其它步骤条件同实施例一。
对实施例一～实施例三以及对比例一～对比例三所得的麝香祛痛巴布膏剂样品进行测试，测试方法参考《中国药典》凝胶贴的相关测试，结果如下表2所示。
表2实施例一至三以及对比例一至七所制得的样品测试结果
由表2可知，本发明膏剂耐热、黏附力、赋形性、含量均匀度、透皮吸收性能、稳定性综合得分高；其中黏着力在1208～1830mN，在保证贴敷性好的同时，又不会紧贴皮肤，保证使用后能够较轻松地取下，避免拉伤皮肤。
实施例四
步骤(3)采用5％的聚丙烯酸钠，0.1％的京尼平，0.5％的聚乙二醇200，94.4％的麝香浸膏药液，其它步骤及条件同实施例一，制得麝香祛痛巴布膏剂。
本发明以聚丙烯酸钠、羧甲基壳聚糖和明胶为骨架、京尼平为交联剂，聚乙二醇200作为溶剂和保湿剂，结果耐热、黏附力、赋形性、含量均匀度、透皮吸收性能、稳定性综合得分最高，各项指标均符合《中国药典》的要求。
以上所述本发明的具体实施方式，并不构成对本发明保护范围的限定。任何根据本发明的技术构思所做出的各种其他相应的改变与变形，均应包含在本发明权利要求的保护范围内。
Claims (4)
1.麝香祛痛巴布膏剂，其特征在于，按质量百分数计，由基质5%、交联剂0.1%、保湿剂0.5%以及94.4%的麝香浸膏组成；基质由质量比为2.2：0.8：2的聚丙烯酸钠、羧甲基壳聚糖和明胶组成；
所述麝香祛痛巴布膏剂的制备方法，包括以下步骤：
按质量百分数计，取5%的基质加入到0.5%的保湿剂中，分散均匀后加入到94.4%的麝香浸膏中，再加入0.1%的交联剂，搅拌至溶解完全得到凝胶，再经过涂布、覆膜、静置和切片，得到麝香祛痛巴布膏剂；
所述交联剂为京尼平；所述保湿剂为聚乙二醇200；
麝香浸膏由如下质量份的原料加乙醇浸提得到：人工麝香0.33份、红花1份、樟脑30份、独活1份、冰片20份、龙血竭0.33份、薄荷脑10份、地黄20份和三七0.33份；
麝香浸膏的制备步骤包括：取人工麝香0.33g、三七0.33g和红花1g，分别用50%乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；地黄20g用50%乙醇100mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；龙血竭0.33g和独活1g分别用乙醇10mL分三次浸渍，每次7天，合并浸渍液，滤过，滤液备用；冰片20g和樟脑30g加入乙醇100mL搅拌使溶解，混匀，加入50%乙醇700mL，加入上述各浸渍液，混匀；将薄荷脑10g用适量50%乙醇溶解，加入所得药液中，加50%乙醇至总量为1000mL，混匀，静置，滤过，即得。
2.根据权利要求1所述的麝香祛痛巴布膏剂，其特征在于，涂布是将凝胶涂布在防渗布上。
3.根据权利要求1所述的麝香祛痛巴布膏剂，其特征在于，覆膜后静置24h再切片。
4.根据权利要求1所述的麝香祛痛巴布膏剂，其特征在于，切片的尺寸为40mm×40mm，每片含药量为1.5～2.5g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210396925.7A CN114681552B (zh) | 2022-04-15 | 2022-04-15 | 麝香祛痛巴布膏剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210396925.7A CN114681552B (zh) | 2022-04-15 | 2022-04-15 | 麝香祛痛巴布膏剂及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114681552A CN114681552A (zh) | 2022-07-01 |
| CN114681552B true CN114681552B (zh) | 2024-02-09 |
Family
ID=82143051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210396925.7A Active CN114681552B (zh) | 2022-04-15 | 2022-04-15 | 麝香祛痛巴布膏剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114681552B (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1729997A (zh) * | 2005-08-03 | 2006-02-08 | 包头中药有限责任公司 | 一种麝香祛痛喷雾剂的制法 |
| CN1840051A (zh) * | 2006-01-23 | 2006-10-04 | 北京因科瑞斯生物制品研究所 | 一种麝香祛痛凝胶及其制备方法 |
| CN105778126A (zh) * | 2016-03-31 | 2016-07-20 | 中国人民解放军军事医学科学院野战输血研究所 | 一种京尼平交联生物凝胶及其制备方法与应用 |
| CN112316205A (zh) * | 2020-11-16 | 2021-02-05 | 中国药科大学 | 一种积雪草苷外用凝胶敷料及其制备方法 |
-
2022
- 2022-04-15 CN CN202210396925.7A patent/CN114681552B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1729997A (zh) * | 2005-08-03 | 2006-02-08 | 包头中药有限责任公司 | 一种麝香祛痛喷雾剂的制法 |
| CN1840051A (zh) * | 2006-01-23 | 2006-10-04 | 北京因科瑞斯生物制品研究所 | 一种麝香祛痛凝胶及其制备方法 |
| CN105778126A (zh) * | 2016-03-31 | 2016-07-20 | 中国人民解放军军事医学科学院野战输血研究所 | 一种京尼平交联生物凝胶及其制备方法与应用 |
| CN112316205A (zh) * | 2020-11-16 | 2021-02-05 | 中国药科大学 | 一种积雪草苷外用凝胶敷料及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114681552A (zh) | 2022-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109394737A (zh) | 医用冷敷贴及其制备方法 | |
| CN111265606A (zh) | 一种活血镇痛组方及活血镇痛凝胶贴膏剂 | |
| CN102178810B (zh) | 一种治疗皮肤溃疡的中药贴膜及其制备方法 | |
| CN114681552B (zh) | 麝香祛痛巴布膏剂及其制备方法 | |
| CN102178811B (zh) | 一种治疗皮肤溃疡的药物及其制备方法 | |
| CN104547797A (zh) | 伤湿止痛巴布剂及其制备方法 | |
| CN104258067A (zh) | 一种用于巴布剂的药物组合物、巴布剂及其制备工艺 | |
| CN101045136A (zh) | 治疗创面感染的药物及其制备方法 | |
| CN102302616B (zh) | 治疗膝骨性关节炎巴布剂及其制备方法 | |
| CN105233328A (zh) | 能促进手术刀口快速愈合的医用无纺布敷料 | |
| CN1827150A (zh) | 一种治疗风湿疾病的外用乳膜及其制备方法 | |
| CN1539508A (zh) | 创面修复敷料基质、敷料及制备工艺 | |
| CN113274444A (zh) | 一种治疗支气管哮喘的贴膏及其制备方法 | |
| CN109908112B (zh) | 一种不过敏的橡胶膏贴膏及其制备方法 | |
| CN107412432B (zh) | 一种用于治疗关节疼痛和关节炎症外用贴膏及其制备方法 | |
| CN111658716A (zh) | 一种水凝胶磁疗中药贴膏及其制备方法 | |
| CN110731992A (zh) | 一种麻痹膏及其制备方法和制备的麻痹贴 | |
| CN104740140B (zh) | 一种治疗烧烫伤的中药外用护理药物 | |
| CN115721674B (zh) | 一种创口护理用组合物及其应用 | |
| CN109662993A (zh) | 医用退热贴及其制备方法 | |
| CN114377116B (zh) | 一种含水蛭素的敷料及其制备方法 | |
| CN115006337B (zh) | 一种用于皮肤创面修复的双层亲水凝胶贴及其制备方法 | |
| CN116173168B (zh) | 一种祛风散寒、舒筋活血、消肿止痛缓释凝胶膏及其制备方法 | |
| CN113975448B (zh) | 一种胶原蛋白复合敷料及其制备方法 | |
| CN105194717B (zh) | 促进手术刀口愈合的海绵剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |